WallStreetZenWallStreetZen

NYSE: BAX
Baxter International Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Baxter International earnings were $108.0M for the trailing 12 months ending Sep 30, 2024, with -95.9% growth year over year. The latest BAX earnings report on Sep 30, 2024 announced Q3 2024 earnings of $140.0M, down 144.6% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, BAX reported annual earnings of $2.7B, with -209.2% growth. The next BAX earnings date is Feb 6, 2025.

BAX past earnings growth

How has BAX's earnings growth performed historically?

Company
-95.91%
Industry
36.64%
Market
48.77%
BAX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
BAX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
BAX's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

BAX earnings history

Current Revenue
$14.0B
Current Earnings
$108.0M
Current Profit Margin
0.8%
BAX's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

BAX Return on Equity

Current Company
1.3%
Current Industry
10%
Current Market
35%
BAX's Return on Equity (1.3%)... subscribe to Premium to read more.
High Return on Equity Performance

BAX Return on Assets

Current Company
0.4%
Current Industry
7.7%
BAX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BAX announces earnings.

BAX Return on Capital Employed

Current Company
3.59%
Current Industry
9.9%
BAX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BAX vs Medical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BAX$1.81B$108.00M-39.45%$0.21
HOLX$1.30B$789.50M-5.72%$3.35
COO$1.11B$392.30M-3.55%$1.97
ATR$738.48M$335.95M+6.54%$5.08
RGEN$118.65M-$8.10MN/A-$0.14
View Top Medical Stocks

BAX earnings dates

Next earnings date
Feb 6, 2025

Baxter International Earnings Reports & History FAQ

What were Baxter International's earnings last quarter?

On BAX's earnings call on Invalid Date, Baxter International (NYSE: BAX) reported Q3 2024 earnings per share (EPS) of $0.27, up 94.55% year over year. Total BAX earnings for the quarter were $140.00 million. In the same quarter last year, Baxter International's earnings per share (EPS) was $4.95.

If you're new to stock investing, here's how to buy Baxter International stock.

When does Baxter International report earnings?

The next BAX earnings call is Invalid Date. Add BAX to your watchlist to be reminded of Baxter International's next earnings date.

What was BAX's earnings growth in the past year?

As of Baxter International's earnings date in Invalid Date, Baxter International's earnings has grown -95.91% year over year. This is 132.54 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 36.64%. BAX earnings in the past year totalled $108.00 million.

Is Baxter International profitable or losing money?

As of the last Baxter International earnings report, Baxter International is currently profitable. Baxter International's net profit (also called net income) for the twelve months ending Sep 30, 2024 was $108.00 million, a 95.83% decrease year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.